THSD7A-positive membranous nephropathy after kidney transplantation: A case report
Nefrología (English Edition), 2023 Membranous nephropathy (MN) is a common cause of nephrotic syndrome after kidney transplantation (KT); however, scarce is known regarding post-KT thrombospondin type-1 domain-containing 7A (THSD7A)-positive MN.
Eulàlia Solà-Porta +8 more
doaj +8 more sources
An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN [PDF]
Renal Failure, 2018 Background: THSD7A is a new target antigen of idiopathic membranous nephropathy (IMN). Moreover, malignancies are also found in patients with THSD7A-positive membranous nephropathy.
Song Ren +6 more
doaj +6 more sources
PLoS ONE, 2011 BackgroundThrombospondin type I domain containing 7A (THSD7A) is a novel neural protein that is known to affect endothelial migration and vascular patterning during development.
Meng-Wei Kuo +4 more
doaj +4 more sources
A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy [PDF]
Journal of Immunology Research, 2021 Membranous nephropathy (MN) is an organ-restricted autoimmune disease mainly caused by circulating autoantibodies against podocyte antigens, including the M-type phospholipase A2 receptor (PLA2R) and thrombospondin domain-containing 7A (THSD7A ...
Pingna Zhang +7 more
doaj +5 more sources
A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy [PDF]
Brazilian Journal of Nephrology, 2019 Idiopathic membranous nephropathy (IMN) is a frequent cause of nephrotic syndrome in adults. In terms of etiology, the condition may be categorized as primary/idiopathic or secondary. Literature on the pathophysiology of IMN has indicated the presence of
David Campos Wanderley +3 more
doaj +7 more sources
Clinical Features and Pathology of PLA2R and THSD7A-Associated Membranous Nephropathy: A Single-Center Study From China [PDF]
ImmunoTargets and TherapyYan Pan, Wei Dong Chen, Lei Liu, Huijuan Yang, Baochao Chang, Caixia Cui Department of Nephrology, First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Province, People’s Republic of ChinaCorrespondence: Wei Dong Chen, Email cwd2012@163 ...
Huijuan Yang
exaly +3 more sources
Characterization of THSD7A-antibodies not binding to glomerular THSD7A in a patient with diabetes mellitus but no membranous nephropathy [PDF]
Scientific Reports, 2021 Membranous nephropathy (MN) is an autoimmune disease caused by autoantibodies against the podocyte antigens phospholipase A2 receptor 1 (PLA2R1) and thrombospondin type 1 domain containing protein 7A (THSD7A) in 80% and 2–3% of patients, respectively ...
Linda Reinhard +8 more
doaj +3 more sources
Differential expression of THSD7A in cancer of the vulva.
, 2021 In these brief notes we document work using published microarray data (1, 2) to pioneer integrative transcriptome analysis comparing vulvar carcinoma to its tissue of origin, the vulva. We report the differential expression of thrombospondin type 1 domain-containing 7A, encoded by THSD7A, in cancer of the vulva.
Shahan Mamoor
openaire +3 more sources
THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A. [PDF]
Adv Sci (Weinh)ABSTRACT Our previous genome‐wide screening has linked THSD7A (thrombospondin type 1 domain containing 7A) gene to human coronary artery disease (CAD). How THSD7A contributes to atherosclerosis, however, remains unclear. In this study,
Liu J +15 more
europepmc +5 more sources
The Turkish Journal of Gastroenterology, 2021 Background: Thrombospondin type 1 domain-containing 7A (THSD7A) has emerged as a new potential molecular tool for multiple tumors since that THSD7A was detected to be expressed in various malignant tumor types including colorectal cancer (CRC).
Oktay Halit Aktepe +8 more
doaj +2 more sources